Scaling-up production of recombinant AAV vectors for clinical applications

Current Opinion in Drug Discovery and Development

Volumn 3, Issue 6, 2000, Pages 750-755

  Qu, G ^a   McClelland, A ^a   Wright, J F ^a  

^a Avigen Inc   (United States)

Author keywords

AAV vector; Gene therapy; Process development; Production; Scale up

Indexed keywords

GENE PRODUCT; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; CELL CULTURE; COLUMN CHROMATOGRAPHY; COST EFFECTIVENESS ANALYSIS; GENE TARGETING; GENE THERAPY; REVIEW; VIRUS PURIFICATION;

EID: 0034530161     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Use of adeno-associated virus as a general transduction vector for mammalian cells
2. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector
3. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
4. Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle
5. Differential and persistent expression patterns of CNS gene transfer by an adeno-essociated virus (AAV) vector
6. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy
7. Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle
8. Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model
9. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
10. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors
11. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
12. Parvoviridea and their replication
13. Nucleotide sequence and organization of the adeno-associated virus 2 genome
14. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus
15. Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication
16. A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication
17. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
18. Cloning of adeno-associated virus into pBR322: Rescue of intact virus from the recombinant plasmid in human cells
19. DNA amplification of adeno-associated virus as a response to cellular genotoxic stress
20. Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line
21. Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression
22. Adeno-associated virus general transduction vectors: Analysis of proviral structures
23. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV
24. Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by non-homologous recombination during AAV vector production
25. Cell lines for the production of recombinant adeno-associated virus
26. A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography
27. Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors
28. AAV vector for cystic fibrosis
29. Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb
30. A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome
31. High-titer adeno-associated virus vectors from a Rep/Cap cell line and hybrid shuttle virus
32. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap
33. Adeno-associated virus vectors can be efficiently produced without helper virus
34. Factors influencing recombinant adeno-associated virus production
35. Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6
36. Scale-up of recombinant adeno-associated virus (rAAV) gene therapy vector production and purification
37. In vitro packaging of adeno-associated virus DNA
38. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses
39. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield
40. Purification of high quality rAAV vectors by column chromatography using the BSO/hybrid production system